全球诊断行业2025财年第一季度业绩亮眼，多家公司财报表现突出。BD公布Q2营收达52.7亿美元，同比增长4.5%，其中医疗板块增长12.7%；因美纳Q1核心营收10.4亿美元，运营效率显著提升，但受大中华区政策影响全年预期下调；索灵Q1营收增长8%，免疫和分子诊断业务稳健增长；Tempus AI Q1营收飙升75%至2.56亿美元，基因组学业务贡献显著。AI与早筛技术成为行业创新的主要驱动力。
Source Link全球诊断行业2025财年第一季度业绩亮眼，多家公司财报表现突出。BD公布Q2营收达52.7亿美元，同比增长4.5%，其中医疗板块增长12.7%；因美纳Q1核心营收10.4亿美元，运营效率显著提升，但受大中华区政策影响全年预期下调；索灵Q1营收增长8%，免疫和分子诊断业务稳健增长；Tempus AI Q1营收飙升75%至2.56亿美元，基因组学业务贡献显著。AI与早筛技术成为行业创新的主要驱动力。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.